Vir Biotechnology (VIR) Goodwill (2018 - 2026)
Vir Biotechnology (VIR) posted Goodwill of $16.9 million for Q1 2026, little changed sequentially from $16.9 million in Q4 2025, and little changed YoY from $16.9 million in Q1 2025.
Vir Biotechnology (VIR) Goodwill (2018 - 2026) Analysis & Trends
Vir Biotechnology has reported Goodwill for 9 years, with the latest figure at $16.9 million in Q1 2026.
- Quarterly Goodwill changed 0.0% year-over-year to $16.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.9 million (changed 0.0% YoY) and the FY2025 annual result came in at $16.9 million, changed 0.0% from the prior year.
- Goodwill was little changed at $16.9 million in Q1 2026 per VIR's latest filing, from $16.9 million in the prior quarter.
- Over five years, Goodwill peaked at $16.9 million in Q3 2024 and troughed at $16.9 million in Q1 2022.
- A 5-year average of $16.9 million and a median of $16.9 million in 2022 frame the typical range for Goodwill.
- The sharpest annual moves came in 2024 and 2025: Goodwill increased 0.01% in 2024, then slipped 0.01% in 2025.
- Over 5 years, Goodwill stood at $16.9 million in 2022, then changed by 0.0% to $16.9 million in 2023, then changed by 0.0% to $16.9 million in 2024, then changed by 0.0% to $16.9 million in 2025, then changed by 0.0% to $16.9 million in 2026.
- According to Business Quant data, Goodwill over the past three periods registered $16.9 million, $16.9 million, and $16.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Vir Biotechnology | 1.56 Bn | 1.56 Bn | 238.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.94 Mn |
| Mar 31, 2026 | 16.94 Mn |
| Dec 31, 2025 | 16.94 Mn |
| Sep 30, 2025 | 16.94 Mn |
| Jun 30, 2025 | 16.94 Mn |
| Mar 31, 2025 | 16.94 Mn |
| Dec 31, 2024 | 16.94 Mn |
| Sep 30, 2024 | 16.94 Mn |
| Jun 30, 2024 | 16.94 Mn |
| Mar 31, 2024 | 16.94 Mn |
| Dec 31, 2023 | 16.94 Mn |
| Sep 30, 2023 | 16.94 Mn |
| Jun 30, 2023 | 16.94 Mn |
| Mar 31, 2023 | 16.94 Mn |
| Dec 31, 2022 | 16.94 Mn |
| Sep 30, 2022 | 16.94 Mn |
| Jun 30, 2022 | 16.94 Mn |
| Mar 31, 2022 | 16.94 Mn |
| Dec 31, 2021 | 16.94 Mn |
| Sep 30, 2021 | 16.94 Mn |